Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
38.04
+1.05 (2.84%)
At close: Jun 26, 2026, 4:00 PM EDT
37.99
-0.05 (-0.13%)
After-hours: Jun 26, 2026, 7:56 PM EDT
Viking Therapeutics Employees
Viking Therapeutics had 53 employees as of December 31, 2025. The number of employees increased by 17 or 47.22% compared to the previous year.
Employees
53
Change (1Y)
17
Growth (1Y)
47.22%
Revenue / Employee
n/a
Profits / Employee
-$8,005,678
Market Cap
4.42B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ACADIA Pharmaceuticals | 798 |
| Arcus Biosciences | 601 |
| Crinetics Pharmaceuticals | 594 |
| Denali Therapeutics | 507 |
| Relay Therapeutics | 193 |
| Catalyst Pharmaceuticals | 182 |
| Celcuity | 155 |
| Edgewise Therapeutics | 154 |
VKTX News
- 3 days ago - Viking catalysts include VK3019, VK2735 readouts in Q3, says Raymond James - TheFly
- 4 days ago - Viking Therapeutics begins Phase 1 SAD clinical trial of VK3019 - TheFly
- 4 days ago - Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy Adults - PRNewsWire
- 12 days ago - Viking Therapeutics management to meet with B. Riley - TheFly
- 17 days ago - Viking Therapeutics names Hubert Chen, M.D., as Chief Medical Officer - TheFly
- 17 days ago - Viking Therapeutics Announces Appointment of Hubert C. Chen, M.D. - PRNewsWire
- 21 days ago - Viking Therapeutics Slides: Corporate presentation - Filings
- 23 days ago - Viking Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts